Sanaby Health Acquisition Corp. I
| General Information | |
| Business: | We intend to capitalize on our management team’s ability to identify, acquire and manage a business that can capitalize on the operational expertise of our management team across a diverse array of healthcare-related industries – with a specific focus on digital health, life science tools and services, and innovative treatment developers. Sandra Shpilberg is our CEO. She is a serial entrepreneur, biotech executive and active investor, with M&A experience. In 2015, Shpilberg founded Seeker Health®, a breakthrough patient-finding platform. The company grew rapidly to serve 60+ biopharmaceutical companies with clinical trial enrollment. In 2018, EVERSANA®, a large life sciences services conglomerate, acquired Seeker Health for an undisclosed sum. Morgan Stanley recognized Seeker Health as a Healthcare Innovator in its 2019 report “Incubators of Innovation: The Role of Private Companies in Healthcare.” (Note: Sanaby Health Acquisition Corp. I priced its SPAC IPO on Oct. 14, 2021, in line with its prospectus: 15 million shares at $10 each to raise $150 million.) |
| Industry: | BLANK CHECKS |
| Employees: | 0 |
| Founded: | 2021 |
| Contact Information | |
| Address | 2625 Middlefield Road #990 Palo Alto, CA 94306 |
| Phone Number | 415-580-1810 |
| Web Address | |
| View Prospectus: | Sanaby Health Acquisition Corp. I |
| Financial Information | |
| Market Cap | $195.0mil |
| Revenues | $0 mil (last 12 months) |
| Net Income | $0 mil (last 12 months) |
| IPO Profile | |
| Symbol | SANBU |
| Exchange | NASDAQ |
| Shares (millions): | 15.0 |
| Price range | $10.00 - $10.00 |
| Est. $ Volume | $150.0 mil |
| Manager / Joint Managers | BTIG |
| CO-Managers | I-Bankers Securities |
| Expected To Trade: | 10/15/2021 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |